Clinical Trials and Drug Development in Neurodegeneration

Clinical Trials and Drug Development in Neurodegeneration focus on advancing innovative therapies to combat progressive neurological disorders such as Alzheimer’s, Parkinson’s, and Huntington’s disease. Cutting-edge clinical research involves rigorous phases to evaluate the safety, efficacy, and tolerability of novel neuroprotective agents and disease-modifying drugs. Leveraging biomarkers, genetic profiling, and advanced imaging technologies accelerates patient stratification and targeted treatment approaches. Ongoing drug development emphasizes slowing neurodegeneration, improving cognitive function, and enhancing quality of life. This dynamic field integrates translational neuroscience and precision medicine, aiming to transform therapeutic strategies and address unmet clinical needs in neurodegenerative disease management worldwide.

    Related Conference of Clinical Trials and Drug Development in Neurodegeneration

    September 22-23, 2025

    6th Annual Congress on Psychiatry

    Paris, France
    October 27-28, 2025

    39th International Conference on Psychiatry and Mental Health

    Amsterdam, Netherlands
    November 10-11, 2025

    International Congress on Cognitive Psychotherapy

    Vancouver, Canada
    November 10-11, 2025

    5th Annual Psychiatrists and Psychologists Meet

    Vancouver, Canada
    November 24-25, 2025

    5thAnnual Congress on Mental Health & Psychiatry

    Barcelona, Spain
    February 16-16, 2026

    43rd Global Psychiatry and Mental Health Conference

    Paris, France
    February 16-17, 2026

    6th Annual Congress on Mental Health

    Paris, France
    March 23-24, 2026

    4th World Congress on Psychiatry

    Tokyo, Japan
    April 13-14, 2026

    8th International Congress on Mental Health

    Tokyo, Japan
    April 20-21, 2026

    33rd World Psychiatrists and Psychologists Meet

    Rome, Italy
    May 27-28, 2026

    8th European Autism Congress

    Paris, France
    June 01-02, 2026

    11th International Conference on Addiction Therapy

    Zurich, Switzerland

    Clinical Trials and Drug Development in Neurodegeneration Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in